The concept of innovative drugs fluctuates and rebounds, JZT hits the limit up

Zhitong
2025.08.14 02:56

The innovative drug concept has rebounded, with JZT hitting the daily limit, Hinova, RemeGen, and Shenzhou Cell rising over 10%, while Fuyuan Pharmaceutical, Kangchen Pharmaceutical, Guangshengtang, and Nuo Cheng Jianhua are among the top gainers

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer